The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.
Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation. Dr.
Neil Sircar, JD, LLM is a human rights lawyer specializing in global and public health, global governance, and health in humanitarian crises. He recently concluded a Fogarty Global Health Fellowship with the National Institutes for Health through the Northern Pacific Global Health Consortium at the University of Washington. He is principal investigator on a study for assessing the implementation of human rights-based approaches to HIV testing and notification in Kenya with the prominent Kenyan non-governmental organization Kenya Legal and Ethical Issues Network.
Dr. Smith's work focuses on tobacco control policy, particularly approaches to the tobacco endgame. Past projects include work on the tobacco industry's influence on and relationships with the lesbian, gay, bisexual and transgender communities, tobacco industry interest in diet and obesity issues, tobacco product waste and pollution, and tobacco control policy issues in the U.S. military.
Joanne Spetz is Director and Brenda and Jeffrey L. Kang Presidential Chair in Health Care Financing at the Philip R. Lee Institute for Health Policy Studies (IHPS), University of California San Francisco. IHPS is a 50-year-old organization that conducts innovative research to support, guide, and enable policymakers, communities, and clinicians in making evidence-informed decisions that improve health and health care for individuals and families.
The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.
Dr. Sung is Professor of Health Economics at the Institute for Health & Aging at UCSF. Her tobacco-related research areas focus on 1) estimating the healthcare costs of cigarette smoking, other tobacco use, and secondhand smoke exposure; 2) economic evaluation of tobacco taxation, other tobacco control policies, and smoking cessation intervention programs; 3) economic impact of smoking on vulnerable populations such as African Americans, Hispanics, low-income people, and persons with mental illness; and 4) global health economics of tobacco use. Dr.
I am a practicing clinical psychologist and Professor of Psychiatry and Behavioral Sciences at the University of California San Francisco (UCSF). I also serve as Co-Director of the Asian American Research Center on Health (AsianARCH.org). The mission of my research program is to promote health equity by developing accessible interventions that can empower individuals and families to make informed health decisions and to take an active role in staying healthy.
Dr. Candy Tsourounis is Professor of Clinical Pharmacy in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California San Francisco. Dr. Tsourounis is involved in providing evidence-based reviews of recently approved prescription medications and performing medication utilization analyses in the Department's Medication Outcomes Center.
Yvette did a PhD in public health ethics at the Centre for Biomedical Ethics, National University of Singapore and a BSc in Biochemistry (Pharmacology) at the University of Surrey, UK. As part of her studies, she was also based at the University of Turku (Finland), Hastings Center (New York), University of Tübingen (Germany), Brocher Foundation (Switzerland), and WHO Regional Office for Europe (Denmark). After her PhD she worked as a Public Health Analyst at Newcastle City Council, UK, and as a freelance consultant for the WHO Regional Office for Europe's tobacco control programme.
We are assessing the dose- and time-response of vascular functional impairment caused by exposure to second hand smoke at very low levels and short exposure times in rats.